No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹47.5Prev. Close
₹44.75Turnover(Lac.)
₹0.35Day's High
₹47.5Day's Low
₹45.7552 Week's High
₹71.9952 Week's Low
₹41Book Value
₹23.19Face Value
₹10Mkt Cap (₹ Cr.)
36P/E
18.19EPS
2.46Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 7.87 | 7.87 | 7.87 | 7.87 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 9.63 | 7.61 | 6.08 | 4.72 |
Net Worth | 17.5 | 15.48 | 13.95 | 12.59 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 26.58 | 27.64 | 18.93 | 29.96 |
yoy growth (%) | -3.85 | 45.99 | -36.81 | -2.06 |
Raw materials | -17.35 | -17.59 | -15.54 | -18.64 |
As % of sales | 65.28 | 63.63 | 82.11 | 62.22 |
Employee costs | -3.76 | -2.36 | -2.14 | -2.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.93 | 0.8 | 0.44 | 0.42 |
Depreciation | -0.81 | -0.76 | -0.52 | -0.51 |
Tax paid | -0.21 | -0.42 | 0.09 | -0.23 |
Working capital | 0.77 | -2.84 | 3.28 | 4.31 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.85 | 45.99 | -36.81 | -2.06 |
Op profit growth | -61.52 | -167.92 | -217.49 | -358.67 |
EBIT growth | -6.08 | 41.31 | -23.07 | 12.72 |
Net profit growth | 92.51 | -31.03 | 187.01 | 9.61 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,738.1 | 98.11 | 4,28,185.32 | 705.44 | 0.9 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,412.7 | 66.77 | 1,71,766.14 | 598 | 0.46 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,337.5 | 66.68 | 1,48,922.76 | 577 | 0.14 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,287.2 | 23.73 | 1,10,081.07 | 90.6 | 0.61 | 4,266.4 | 377.55 |
Cipla Ltd CIPLA | 1,347.65 | 23.94 | 1,09,680.46 | 616.88 | 1.18 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
T G Raghavendra
E D & Wholetime Director
V J Sarma
Independent Non Exe. Director
A Satyanarayana Murthy
Independent Non Exe. Director
O Mohan Rao
Independent Non Exe. Director
Karunasree Samudrala
Independent Non Exe. Director
Muttaraju Venu Manohar
Independent Non Exe. Director
Gantla Venkat Reddy
Company Sec. & Compli. Officer
VENKATA LAKSHMI INDANI
17/745 Alur Road,
Kurnool District,
Andhra Pradesh - 518301
Tel: -
Website: http://www.roopaindustries.com
Email: investors.roopa@gmail.com; info@roopaindustries.co
1-2-285 Domalguda,
Hyderabad - 500 029
Tel: 91-040-27638111/4445
Website: www.aarthiconsultants.com
Email: info@aarthiconsultants.com
Summary
Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Che...
Read More
Reports by Roopa Industries Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.